This bill amends current New Jersey law to allow pharmacists to transfer prescriptions for Schedule II controlled dangerous substances specifically prescribed for attention-deficit/hyperactivity disorder (ADHD) to other pharmacists. The new legal language states that such transfers must comply with federal regulations, thereby expanding the existing framework that currently permits the transfer of Schedule III-V prescriptions. This change aims to enhance the flexibility and accessibility of ADHD medications for patients, particularly in situations where a specific pharmacy may not have the medication available.

The bill addresses the challenges faced by patients who are unable to fill their prescriptions at a particular pharmacy, which often requires them to seek a new prescription from their healthcare provider. By enabling pharmacists to directly transfer ADHD prescriptions, the bill streamlines the process and reduces the burden on both patients and healthcare providers. This legislative change is expected to improve the efficiency of prescription fulfillment for ADHD medications, especially in light of recent federal rule changes that allow for the transfer of controlled substance prescriptions between licensed pharmacies. The act will take effect 60 days after its enactment.

Statutes affected:
Introduced: 45:14-58